Europe Respiratory Inhalers Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type [Nebulizers, Metered Dose Inhalers (MDI), and Dry Powder Inhalers], Technology (Manually Operated Inhalers and Digitally Operated Inhalers), and Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Others)
The Europe respiratory inhalers market is expected to grow from US$ 7,674.02 million in 2022 to US$ 10,470.53 million by 2028. It is estimated to register a CAGR of 5.3% from 2022 to 2028.
Rising Cases of Respiratory Disorders Fueling Europe Respiratory Inhalers Market Growth
The prevalence of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory diseases is increasing across the region. In addition, one of the major causes of respiratory diseases such as COPD and asthma is the rise in air pollution. The Organization for Economic Co-operation and Development (OECD) estimates that global emissions of greenhouse gases are likely to increase by ~50% by 2050, mainly due to a 70% increase in CO2 emissions. In addition, it is estimated that the atmospheric concentration of greenhouse gases could reach 685 parts per million (ppm) CO2 equivalent by 2050, which would cause average temperatures to rise 3–6?C above pre-industrial levels. In addition, the beneficial effects on patients through combination therapy for asthma have increased, which has increased the demand for respiratory inhalers such as dry powder inhalers and soft-mist inhalers, as they are one of the best ways to administer combination drugs. Hence, the increasing prevalence of respiratory diseases among the growing population is one of the factors driving the Europe respiratory inhalers market.
Europe Respiratory Inhalers Market Overview
Europe includes France, Germany, Italy, Spain, the UK, and the Rest of Europe. The region is expected to witness a steady growth rate of 5.3% from 2022 to 2028. Germany dominated the Europe respiratory inhalers market in 2022. According to the OECD 2021 report, there was an increase in the cases of respiratory diseases such as COPD and influenza (particularly during the COVID-19 pandemic) in Germany. As per the Federal Statistical Office (Destatis), Germany, ~75,500 people died of smoking-specific illnesses in Germany in 2020; 46,100 of these cases were due to lung, bronchial, laryngeal, or tracheal cancer, and 29,400 due to COPD. It also reported that the risk of women dying from such illnesses had risen significantly in the last 20 years. In 2020, 40 women per 100,000 inhabitants died of lung and bronchial cancer, corresponding to ~73% of lung and bronchial cancer. Further, according to Germany's Robert Koch Institute (RKI), 4.5 million people suffered from an acute respiratory illness (ARE) within one week at the end of June and the beginning of July in 2022. Thus, the increasing prevalence of respiratory diseases in the country is expected to fuel the demand for respiratory inhalers.
Europe Respiratory Inhalers Market Revenue and Forecast to 2028 (US$ Million)
Europe Respiratory Inhalers Market Segmentation
The Europe respiratory inhalers market is segmented based on product type, technology, disease indication, and country.
Based on product type, the Europe respiratory inhalers market is segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment held the largest share of the Europe respiratory inhalers market in 2022.
Based on technology, the Europe respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger share of the Europe respiratory inhalers market in 2022.
Based on disease indication, the Europe respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the Europe respiratory inhalers market in 2022.
Based on country, the Europe respiratory inhalers market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe respiratory inhalers market in 2022.
AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd; GSK Plc; Koninklijke Philips NV; OMRON Corp; OPKO Health, Inc; PARI Respiratory Equipment, Inc.; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the Europe respiratory inhalers market.
Rising Cases of Respiratory Disorders Fueling Europe Respiratory Inhalers Market Growth
The prevalence of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory diseases is increasing across the region. In addition, one of the major causes of respiratory diseases such as COPD and asthma is the rise in air pollution. The Organization for Economic Co-operation and Development (OECD) estimates that global emissions of greenhouse gases are likely to increase by ~50% by 2050, mainly due to a 70% increase in CO2 emissions. In addition, it is estimated that the atmospheric concentration of greenhouse gases could reach 685 parts per million (ppm) CO2 equivalent by 2050, which would cause average temperatures to rise 3–6?C above pre-industrial levels. In addition, the beneficial effects on patients through combination therapy for asthma have increased, which has increased the demand for respiratory inhalers such as dry powder inhalers and soft-mist inhalers, as they are one of the best ways to administer combination drugs. Hence, the increasing prevalence of respiratory diseases among the growing population is one of the factors driving the Europe respiratory inhalers market.
Europe Respiratory Inhalers Market Overview
Europe includes France, Germany, Italy, Spain, the UK, and the Rest of Europe. The region is expected to witness a steady growth rate of 5.3% from 2022 to 2028. Germany dominated the Europe respiratory inhalers market in 2022. According to the OECD 2021 report, there was an increase in the cases of respiratory diseases such as COPD and influenza (particularly during the COVID-19 pandemic) in Germany. As per the Federal Statistical Office (Destatis), Germany, ~75,500 people died of smoking-specific illnesses in Germany in 2020; 46,100 of these cases were due to lung, bronchial, laryngeal, or tracheal cancer, and 29,400 due to COPD. It also reported that the risk of women dying from such illnesses had risen significantly in the last 20 years. In 2020, 40 women per 100,000 inhabitants died of lung and bronchial cancer, corresponding to ~73% of lung and bronchial cancer. Further, according to Germany's Robert Koch Institute (RKI), 4.5 million people suffered from an acute respiratory illness (ARE) within one week at the end of June and the beginning of July in 2022. Thus, the increasing prevalence of respiratory diseases in the country is expected to fuel the demand for respiratory inhalers.
Europe Respiratory Inhalers Market Revenue and Forecast to 2028 (US$ Million)
Europe Respiratory Inhalers Market Segmentation
The Europe respiratory inhalers market is segmented based on product type, technology, disease indication, and country.
Based on product type, the Europe respiratory inhalers market is segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment held the largest share of the Europe respiratory inhalers market in 2022.
Based on technology, the Europe respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger share of the Europe respiratory inhalers market in 2022.
Based on disease indication, the Europe respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the Europe respiratory inhalers market in 2022.
Based on country, the Europe respiratory inhalers market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe respiratory inhalers market in 2022.
AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd; GSK Plc; Koninklijke Philips NV; OMRON Corp; OPKO Health, Inc; PARI Respiratory Equipment, Inc.; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the Europe respiratory inhalers market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Respiratory Inhalers Market – by Product Type
1.3.2 Europe Respiratory Inhalers Market – by Technology
1.3.3 Europe Respiratory Inhalers Market – by Disease Indication
1.3.4 Europe Respiratory Inhalers Market – by Country
2. EUROPE RESPIRATORY INHALERS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE RESPIRATORY INHALERS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert’s Opinion
5. EUROPE RESPIRATORY INHALERS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Cases of Respiratory Disorders
5.1.2 Growing Adoption of Generic Inhalers
5.2 Market Restraints
5.2.1 Lack of Early Diagnosis and High Cost of Inhalers
5.3 Market Opportunities
5.3.1 Increasing Adoption of Smart Inhalers Technology
5.4 Future Trends
5.4.1 Increasing Product Development Activities
5.5 Impact Analysis
6. RESPIRATORY INHALERS MARKET – EUROPE ANALYSIS
6.1 Europe Respiratory Inhalers Market Revenue Forecast and Analysis
7. EUROPE RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – BY PRODUCT TYPE
7.1 Overview
7.2 Europe Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Dry Powder Inhalers
7.3.1 Overview
7.3.2 Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Multi-Dose Dry Powder Inhalers
7.3.3.1 Overview
7.3.3.2 Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Single Dose Dry Powder Inhalers
7.3.4.1 Overview
7.3.4.2 Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metered Dose Inhalers
7.4.1 Overview
7.4.2 Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Pressured Metered Dose Inhalers
7.4.3.1 Overview
7.4.3.2 Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Connected Metered Dose Inhalers
7.4.4.1 Overview
7.4.4.2 Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Nebulizers
7.5.1 Overview
7.5.2 Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Compressed Air Nebulizers
7.5.3.1 Overview
7.5.3.2 Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Mesh Air Nebulizers
7.5.4.1 Overview
7.5.4.2 Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Ultrasonic Air Nebulizers
7.5.5.1 Overview
7.5.5.2 Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8. EUROPE RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY TECHNOLOGY
8.1 Overview
8.2 Europe Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
8.3 Manually Operated Inhalers
8.3.1 Overview
8.3.2 Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Digitally Operated Inhalers
8.4.1 Overview
8.4.2 Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9. EUROPE RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY DISEASE INDICATION
9.1 Overview
9.2 Europe Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
9.3 Asthma
9.3.1 Overview
9.3.2 Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 COPD
9.4.1 Overview
9.4.2 COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Arterial Hypertension
9.5.1 Overview
9.5.2 Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10. EUROPE RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.1 Overview
10.1.1.1.2 UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.3 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.1.3.1 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.1.3.2 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.1.3.3 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.1.4 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.1.5 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.1.1.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.1 Overview
10.1.1.2.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.3 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.2.3.1 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.2.3.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.2.3.3 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.2.4 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.2.5 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.1.1.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.1 Overview
10.1.1.3.2 France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.3.3.1 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.3.3.2 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.3.3.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.3.4 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.3.5 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.1.1.4 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.4.1 Overview
10.1.1.4.2 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.4.3 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.4.3.1 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.4.3.2 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.4.3.3 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.4.4 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.4.5 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.1.1.5 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.5.1 Overview
10.1.1.5.2 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.5.3 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.5.3.1 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.5.3.2 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.5.3.3 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.5.4 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.5.5 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.1.1.6 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.6.3 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.6.3.1 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.6.3.2 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.6.3.3 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.6.4 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.6.5 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 AstraZeneca Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Beximco Pharmaceuticals Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boehringer Ingelheim International GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cipla Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GSK Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 OMRON Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PARI Respiratory Equipment, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 OPKO Health, Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Respiratory Inhalers Market – by Product Type
1.3.2 Europe Respiratory Inhalers Market – by Technology
1.3.3 Europe Respiratory Inhalers Market – by Disease Indication
1.3.4 Europe Respiratory Inhalers Market – by Country
2. EUROPE RESPIRATORY INHALERS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE RESPIRATORY INHALERS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert’s Opinion
5. EUROPE RESPIRATORY INHALERS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Cases of Respiratory Disorders
5.1.2 Growing Adoption of Generic Inhalers
5.2 Market Restraints
5.2.1 Lack of Early Diagnosis and High Cost of Inhalers
5.3 Market Opportunities
5.3.1 Increasing Adoption of Smart Inhalers Technology
5.4 Future Trends
5.4.1 Increasing Product Development Activities
5.5 Impact Analysis
6. RESPIRATORY INHALERS MARKET – EUROPE ANALYSIS
6.1 Europe Respiratory Inhalers Market Revenue Forecast and Analysis
7. EUROPE RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – BY PRODUCT TYPE
7.1 Overview
7.2 Europe Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Dry Powder Inhalers
7.3.1 Overview
7.3.2 Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Multi-Dose Dry Powder Inhalers
7.3.3.1 Overview
7.3.3.2 Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Single Dose Dry Powder Inhalers
7.3.4.1 Overview
7.3.4.2 Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metered Dose Inhalers
7.4.1 Overview
7.4.2 Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Pressured Metered Dose Inhalers
7.4.3.1 Overview
7.4.3.2 Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Connected Metered Dose Inhalers
7.4.4.1 Overview
7.4.4.2 Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Nebulizers
7.5.1 Overview
7.5.2 Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Compressed Air Nebulizers
7.5.3.1 Overview
7.5.3.2 Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Mesh Air Nebulizers
7.5.4.1 Overview
7.5.4.2 Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Ultrasonic Air Nebulizers
7.5.5.1 Overview
7.5.5.2 Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8. EUROPE RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY TECHNOLOGY
8.1 Overview
8.2 Europe Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
8.3 Manually Operated Inhalers
8.3.1 Overview
8.3.2 Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Digitally Operated Inhalers
8.4.1 Overview
8.4.2 Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9. EUROPE RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY DISEASE INDICATION
9.1 Overview
9.2 Europe Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
9.3 Asthma
9.3.1 Overview
9.3.2 Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 COPD
9.4.1 Overview
9.4.2 COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Arterial Hypertension
9.5.1 Overview
9.5.2 Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10. EUROPE RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.1 Overview
10.1.1.1.2 UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.3 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.1.3.1 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.1.3.2 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.1.3.3 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.1.4 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.1.5 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.1.1.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.1 Overview
10.1.1.2.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.3 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.2.3.1 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.2.3.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.2.3.3 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.2.4 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.2.5 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.1.1.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.1 Overview
10.1.1.3.2 France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.3.3.1 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.3.3.2 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.3.3.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.3.4 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.3.5 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.1.1.4 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.4.1 Overview
10.1.1.4.2 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.4.3 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.4.3.1 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.4.3.2 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.4.3.3 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.4.4 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.4.5 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.1.1.5 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.5.1 Overview
10.1.1.5.2 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.5.3 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.5.3.1 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.5.3.2 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.5.3.3 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.5.4 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.5.5 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.1.1.6 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.6.3 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.1.1.6.3.1 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.1.1.6.3.2 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.1.1.6.3.3 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.1.1.6.4 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.1.1.6.5 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 AstraZeneca Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Beximco Pharmaceuticals Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boehringer Ingelheim International GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cipla Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GSK Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 OMRON Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PARI Respiratory Equipment, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 OPKO Health, Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. UK Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. UK Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 3. UK Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 4. UK Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 5. UK Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 6. UK Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Germany Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 9. Germany Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 10. Germany Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 11. Germany Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. France Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. France Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 15. France Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 16. France Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 17. France Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 18. France Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 21. Italy Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 22. Italy Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 23. Italy Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 25. Spain Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Spain Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 27. Spain Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of Europe Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Europe Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Europe Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 37. Recent Inorganic Growth Strategies
Table 38. Recent Organic Growth Strategies
Table 39. Glossary of Terms
Table 1. UK Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. UK Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 3. UK Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 4. UK Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 5. UK Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 6. UK Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Germany Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 9. Germany Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 10. Germany Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 11. Germany Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. France Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. France Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 15. France Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 16. France Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 17. France Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 18. France Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 21. Italy Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 22. Italy Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 23. Italy Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 25. Spain Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Spain Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 27. Spain Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of Europe Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Europe Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Europe Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 37. Recent Inorganic Growth Strategies
Table 38. Recent Organic Growth Strategies
Table 39. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Respiratory Inhalers Market Segmentation
Figure 2. Europe Respiratory Inhalers Market, by Country
Figure 3. Europe Respiratory Inhalers Market Overview
Figure 4. Europe Respiratory Inhalers Market, By Product
Figure 5. Europe Respiratory Inhalers Market, By Country
Figure 6. Europe: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Europe Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Respiratory Inhalers Market – Revenue Forecast and Analysis
Figure 10. Europe Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 11. Dry Powder Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Multi-Dose Dry Powder Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Single Dose Dry Powder Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Metered Dose Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pressured Metered Dose Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Connected Metered Dose Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Compressed Air Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Mesh Air Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ultrasonic Air Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
Figure 22. Manually Operated Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Digitally Operated Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
Figure 25. Asthma: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. COPD: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Pulmonary Arterial Hypertension: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe Respiratory Inhalers Market Revenue overview, by Country, 2021 (US$ MN)
Figure 30. Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Country (%)
Figure 31. UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 1. Europe Respiratory Inhalers Market Segmentation
Figure 2. Europe Respiratory Inhalers Market, by Country
Figure 3. Europe Respiratory Inhalers Market Overview
Figure 4. Europe Respiratory Inhalers Market, By Product
Figure 5. Europe Respiratory Inhalers Market, By Country
Figure 6. Europe: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Europe Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Respiratory Inhalers Market – Revenue Forecast and Analysis
Figure 10. Europe Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 11. Dry Powder Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Multi-Dose Dry Powder Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Single Dose Dry Powder Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Metered Dose Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pressured Metered Dose Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Connected Metered Dose Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Compressed Air Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Mesh Air Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ultrasonic Air Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
Figure 22. Manually Operated Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Digitally Operated Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
Figure 25. Asthma: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. COPD: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Pulmonary Arterial Hypertension: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe Respiratory Inhalers Market Revenue overview, by Country, 2021 (US$ MN)
Figure 30. Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Country (%)
Figure 31. UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
